Christianne Roumie, MD, MPH, answers our questions about her new study, which compared the incidence of diabetes and impaired fasting glucose among participants from the SPRINT Randomized Trial.
In a recent study, researchers assessed the relationship and resulting impact of exercise capacity on all-cause mortality risk among people with type 2 diabetes. Lead study author Yun-Ju Lai, MD, discussed...
Aveni Haynes, PhD, discusses findings from her new study, which suggested that improvements in HbA1c and decreases in severe hypoglycemia rates have occurred concurrently over the past 2 decades in the...
David C. Lee, MD, answered our questions about his new study, which indicated that an intervention involving rapid point-of-care HbA1c testing in barbershops could help identify undiagnosed diabetes and...
Endocrinology Consultant spoke with Derek LeRoith, MD, PhD, member of the task force that developed the Endocrine Society’s 2019 clinical practice guideline for the treatment of diabetes in older adults. ...
Endocrinology Consultant spoke with Christian Hampp, PhD, from the US Food and Drug Administration, whose study found high rates of diabetic ketoacidosis when sodium-glucose cotransporter 2 inhibitors are...
Endocrinology Consultant spoke with James Rosenzweig, MD, chair of the task force that developed the Endocrine Society’s clinical practice guideline for the primary prevention of atherosclerotic...
New research suggests many older adults with type 2 diabetes believe factors including longer disease duration, more established complications, and more comorbidities warrant more aggressive diabetes...
Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
Consultant360 spoke with Blánaid Hicks, PhD, BSc, from Queen’s University Belfast, whose study found that the use of angiotensin converting enzyme inhibitors may be tied to an increased lung cancer risk...